Current and historical daily PE Ratio for EOM Pharmaceutical Holdings Inc (
) from 2006 to May 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. EOM Pharmaceutical stock (IMUC) PE ratio as of May 22 2024 is 0.
More Details
EOM Pharmaceutical Holdings Inc (IMUC) PE Ratio (TTM) Chart
EOM Pharmaceutical Holdings Inc (IMUC) PE Ratio (TTM) Historical Data
View and export this data going back to 2006. Start your Free Trial
Total 0
- 1
| EOM Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
EOM Pharmaceutical Holdings Inc (IMUC) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
EOM Pharmaceutical Holdings Inc
NAICS : 541714
SIC : 8731
ISIN : US4525362046
Description
EOM Pharmaceutical Holdings Inc is a clinical-stage biotechnology company that is focused on developing drugs with the potential to transform therapeutic paradigms and improve the lives of patients suffering from debilitating and sometimes deadly diseases. Its pipeline includes compound EOM613, an investigational novel dynamically dual-acting immunomodulator. EOM613 is a peptide nucleic-acid solution with both anti-inflammatory and pro-inflammatory broad-spectrum cytokine effects.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers